15,052
edits
Helminthic therapy and COVID-19: Difference between revisions
→The emerging science: Added a citation.
(→Reactions to a COVID-19 vaccine: Added another quote and source link.) |
(→The emerging science: Added a citation.) |
||
| Line 16: | Line 16: | ||
== The emerging science == | == The emerging science == | ||
* 2022 Jun 28 [https://pubmed.ncbi.nlm.nih.gov/35764965/ Helminth antigens differentially modulate the activation of CD4 + and CD8 + T lymphocytes of convalescent COVID-19 patients in vitro] | |||
:{{Quote|indent}}Our data offer a plausible explanation for the moderate incidence of COVID-19 in Africa and support the hypothesis that helper T cell-mediated immune responses to SARS-CoV-2 are mitigated in the presence of helminth antigens, while virus-specific cytotoxic T cell responses are maintained.{{Quote|/indent}} | |||
* 2022 Feb 11 [https://pubmed.ncbi.nlm.nih.gov/35222441/ The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?] -- [https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8874793/ Full text] | [https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8874793/pdf/fimmu-13-849465.pdf PDF] | * 2022 Feb 11 [https://pubmed.ncbi.nlm.nih.gov/35222441/ The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?] -- [https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8874793/ Full text] | [https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8874793/pdf/fimmu-13-849465.pdf PDF] | ||